Meeting Objectives:
A. Provide evidence-based recommendations for treatment of newly diagnosed and recurrent lung or esophageal cancer
B. Implement treatment plan for thoracic cancer patients using modalities discussed by specialists involved in patients’ care
C. Remain current on treatment techniques and options, including research protocols, available to thoracic cancer patients
D. Teach newer considerations and treatment options, and share clinical experiences needed to obtain best outcomes
Topics for discussion:
No pathology or radiology review cases (Consults from)
K.S.
George Haasler, MD. Thoracic Surgery
Others involved in care: William Bradley, MD., Janet Osborne, MD., Beth Erickson, MD.
Working Stage: 74 y/o with metastatic ovarian cancer actively receiving treatment has new esophageal bleeding. Treatment options? Stenting?
Staging discussed? / Yes / NoClinical trials discussed? / Yes / No
R.B
George Haasler, MD. Thoracic Surgery
Others involved in care:.
Working Stage: 74 y/o male with adenoCA of LLL with mets to L sacrum.
Staging discussed? / Yes / NoClinical trials discussed? / Yes / No
I.J.
Ben George, MD. Medical Oncology
Others involved in care:
Working Stage: 57 y/o with esophageal cancer, s/p chemotherapy. Review latest PET scan and discuss Rx options.
Staging discussed? / Yes / NoClinical trials discussed? / Yes / No
D.L.
Ben George, MD. Medical Oncology
Others involved in care:
Working Stage: 84 y/o male with metastatic ampullary cancer with 2 RLL nodules slowly increasing in size. Discuss Rx options.
Staging discussed? / Yes / NoClinical trials discussed? / Yes / No
*NCCN and other national guidelines are used in patient treatment planning unless otherwise stated by the physician
The next Thoracic Tumor Board will be held Thursday January 16th, 2014
If you would like to present a case at a future Tumor Board please contact:
Julie Bluma at or leave a message at 805-6302.
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education to physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity a maximum of 1.0 AMA PRA Category 1 Credit(s) ™.Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours ofParticipation for Allied Health Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
In accordance with the ACCME policy on relevant financial disclosure, all speakers/planners were asked to reveal any relevant financial relationships. All planners and presenters have disclosed that they have no commercial interests.